Fig. 10From: Overweight with HBV infection limited the efficacy of TACE in hepatocellular carcinoma by inhibiting the upregulated HMGB1The change of HMGB1 expression level after treatment is related to the patient’s PFS / OS. HMGB1 = high-mobility group protein 1; PFS = progression-free survival; OS = overall survivalBack to article page